Aβ induces oxidative stress in senescence-accelerated (SAMP8) mice

Bioscience, Biotechnology and Biochemistry

Volumn 79, Issue 6, 2015, Pages 912-918

  Takagane, Kurara ^a   Nojima, Jun ^a   Mitsuhashi, Hiroaki ^a   Suo, Satoshi ^a   Yanagihara, Dai ^a   Takaiwa, Fumio ^b   Urano, Yasuomi ^c   Noguchi, Noriko ^c   Ishiura, Shoichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL INSTITUTE OF AGROBIOLOGICAL SCIENCES   (Japan)

^c DOSHISHA UNIVERSITY   (Japan)

Author keywords

4 hydroxynonenal; Alzheimer's disease; Amyloid; Edible vaccine; Oxidative stress

Indexed keywords

CELL DEATH; GLYCOPROTEINS; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; VACCINES;

4-HYDROXY-NONENAL; ALZHEIMER'S DISEASE; AMYLOID; AMYLOID BETAS; CULTURE MEDIUM; EDIBLE VACCINES; LARGE AMOUNTS; SH SY5Y CELLS;

MAMMALS;

MUS;

4-HYDROXY-2-NONENAL; ALDEHYDE; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA-PROTEIN (1-42); BUFFER; PEPTIDE FRAGMENT; VACCINE;

AGING; ALZHEIMER DISEASE; ANIMAL; BRAIN; CHEMISTRY; GENETICS; HUMAN; MALE; MAZE TEST; METABOLISM; MOUSE; ORYZA; OXIDATIVE STRESS; PATHOPHYSIOLOGY; SOLUBILITY; TRANSGENIC MOUSE;

AGING; ALDEHYDES; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; BUFFERS; HUMANS; MALE; MAZE LEARNING; MICE; MICE, TRANSGENIC; ORYZA; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; SOLUBILITY; VACCINES;

EID: 84940051452     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1080/09168451.2014.1002449     Document Type: Article

References (42)

1. Markesbery WR. Oxidative stress hypothesis in Alzheimer's Disease. Free Radical Biol. Med. 1997; 23:134-147.
2. Butterfield DA, Drake J, Pocernich C., Castegna A. Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. Trends Mol. Med. 2001; 7:548-554.
3. Butterfield DA, Lauderback CM. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free Radical Biol. Med. 2002; 32:1050-1060.
4. Montine TJ, Neely MD, Quinn J.F., Beal MF, Markesbery WR, Roberts LJ, Morrow JD. Lipid peroxidation in aging brain and Alzheimer's disease. Free Radical Biol. Med. 2002; 33:620-626.
5. Lauderback CM, Hackett JM, Huang F.F., Keller JN, Szweda LI, Markesbery WR, Butterfield DA. The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42. J. Neurochem. 2001; 78:413-416.
6. Di Domenico F, Pupo G, Tramutola A., Giorgi A, Schinina ME, Coccia R, Head E., Butterfield DA, Perluigi M. Redox proteomics analysis of HNE-modified proteins in Down syndrome brain: clues for understanding the development of Alzheimer disease. Free Radical Biol. Med. 2014; 71C:270-280.
7. Pryor WA, Porter NA. Suggested mechanisms for the production of 4-hydroxy-2-nonenal from the autoxidation of polyunsaturated fatty acids. Free Radical Biol. Med. 1990; 8:541-543.
8. Sayre LM, Zelasko DA, Harris P.L., Perry G., Salomon RG, Smith MA. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J. Neurochem. 1997; 68:2092-2097.
9. Hensley K, Butterfield DA, Hall N, Cole P., Subramaniam R, Mark R, Mattson M.P., Markesbery WR, Harris ME, Aksenov M, Aksenova M, Wu JF, Carney JM. Reactive oxygen species as causal agents in the neurotoxicity of the Alzheimer's disease-associated amyloid beta peptide. Ann. N.Y. Acad. Sci. 1996; 786:120-134.
10. Markesbery WR, Lovell MA. Four-hydroxynonenal, a Product of lipid peroxidation, is Increased in the brain in Alzheimer's disease. Neurobiol. Aging. 1998; 19:33-36.
11. McGrath LT, McGleenon BM, Brennan S, McColl D., Mc IS, Passmore AP. Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde. QJM. 2001; 94:485-490.
12. Yatin SM, Varadarajan S, Link C.D., Butterfield DA. In vitro and in vivo oxidative stress associated with Alzheimer's amyloid beta-peptide (1-42). Neurobiol. Aging. 1999; 20:325-330.
13. Schenk D, Barbour R, Dunn W., Gordon G, Grajeda H, Guido T., Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Liao Z, Lieberburg I, Motter R, Mutter L, Soriano F, Shopp G, Vasquez N, Vandevert C, Walker S, Wogulis M, Yednock T, Games D, Seubert P. Immunization with amyloid-beta attenuates Alzheimer disease-like pathology in the PDAPP mouse. Nature. 1999; 400:173-177.
14. Orgogozo JM, Gilman S, Dartigues J.F., Laurent B., Puel M, Kirby LC, Jouanny P, Dubois B., Eisner L, Flitman S, Michel BF, Boada M, Frank A, Hock C. Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization. Neurology. 2003; 61:46-54.
15. Ishii-Katsuno R, Nakajima A, Katsuno T., Nojima J, Futai E, Sasagawa N., Yoshida T, Watanabe Y, Ishiura S. Reduction of amyloid beta-peptide accumulation in Tg2576 transgenic mice by oral vaccination. Biochem. Biophys. Res. Commun. 2010; 399:593-599.
16. Bland PW, Britton DC. Morphological study of antigen-sampling structures in the rat large intestine. Infect. Immun. 1984; 43:693-699.
17. Oono Y, Wakasa Y, Hirose S., Yang L, Sakuta C, Takaiwa F. Analysis of ER stress in developing rice endosperm accumulating beta-amyloid peptide. Plant Biotechnol. J. 2010; 8:691-718.
18. Yoshida T, Kimura E, Koike S., Nojima J, Futai E, Sasagawa N., Watanabe Y, Ishiura S. Transgenic rice expressing amyloid beta-peptide for oral immunization. Int. J. Biol. Sci. 2011; 7:301-307.
19. Nojima J, Maeda A, Aoki S., Suo S, Yanagihara D, Watanabe Y., Yoshida T, Ishiura S. Effect of rice-expressed amyloid beta in the Tg2576 Alzheimer's disease transgenic mouse model. Vaccine. 2011; 29:6252-6258.
20. Takemura M, Nakamura S, Akiguchi I., Ueno M, Oka N, Ishikawa S., Shimada A, Kimura J, Takeda T. Beta/A4 proteinlike immunoreactive granular structures in the brain of senescence-accelerated mouse. Am. J. Pathol. 1993; 142:1887-1897.
21. Takeda T, Hosokawa M, Takeshita S., Irino M, Higuchi K, Matsushita T., Tomita Y, Yasuhira K, Hamamoto H, Shimizu K, Ishii M, Yamamuro T. A new murine model of accelerated senescence. Mech. Ageing Dev. 1981; 17:183-194.
22. Pallas M, Camins A, Smith M.A., Perry G., Lee HG, Casadesus G From aging to Alzheimer's disease: unveiling "the switch" with the senescence-accelerated mouse model (SAMP8). J. Alzheimers Dis. 2008; 15:615-624.
23. Ueno M, Akiguchi I, Hosokawa M., Shinnou M, Sakamoto H, Takemura M., Higuchi K. Age-related changes in the brain transfer of blood-borne horseradish peroxidase in the hippocampus of senescence-accelerated mouse. Acta Neuropathol. 1997; 93:233-240.
24. Morley JE, Kumar VB, Bernardo A.E., Farr SA, Uezu K, Tumosa N, Flood JF. Beta-amyloid precursor polypeptide in SAMP8 mice affects learning and memory. Peptides. 2000; 21:1761-1767.
25. Kanno T, Yaguchi T, Shimizu T., Tanaka A, Nishizaki T. 8-[2-(2-pentyl-cyclopropylmethyl)-cyclopropyl]-octanoic acid and its diastereomers improve age-related cognitive deterioration. Lipids. 2012; 47:687-695.
26. Orejana L, Barros-Minones L, Jordan J., Puerta E, Aguirre N. Sildenafil ameliorates cognitive deficits and tau pathology in a senescence-accelerated mouse model. Neurobiol. Aging. 2012; 33:e11-20.
27. Miyamoto M, Kiyota Y, Yamazaki N., Nagaoka A, Matsuo T, Nagawa Y., Takeda T. Age-related changes in learning and memory in the senescence-accelerated mouse (SAM). Physiol. Behav. 1986; 38:399-406.
28. Wang F, Chen H, Sun X. Age-related spatial cognitive impairment is correlated with a decrease in ChAT in the cerebral cortex, hippocampus and forebrain of SAMP8 mice. Neurosci. Lett. 2009; 454:212-217.
29. Farr SA, Poon HF, Dogrukol-Ak D, Drake J., Banks WA, Eyerman E, Butterfield DA, Morley JE. The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. J. Neurochem. 2003; 84:1173-1183.
30. Maurice T, Roman FJ, Su T.P., Privat A. Beneficial effects of sigma agonists on the age-related learning impairment in the senescence-accelerated mouse (SAM). Brain Res. 1996; 733: 219-230.
31. Dahlgren KN, Manelli AM, Stine WB Jr, Baker LK, Krafft GA, LaDu MJ. Oligomeric and fibrillar species of amyloid-beta pep-tides differentially affect neuronal viability. J. Biol. Chem. 2002; 277:32046-32053.
32. Yagishita S, Morishima-Kawashima M, Tanimura Y., Ishiura S, Ihara Y. DAPT-induced intracellular accumulations of longer amyloid beta-proteins: further implications for the mechanism of intramembrane cleavage by gamma-secretase. Biochemistry. 2006; 45:3952-3960.
33. Yonemura Y, Futai E, Yagishita S., Suo S, Tomita T, Iwatsubo T., Ishiura S. Comparison of presenilin 1 and presenilin 2 gamma-secretase activities using a yeast reconstitution system. J. Biol. Chem. 2011; 286:44569-44575.
34. Kopniczky Z, Dochnal R, Macsai M., Pal A, Kiss G, Mihaly A., Szabo G. Alterations of behavior and spatial learning after unilateral entorhinal ablation of rats. Life Sci. 2006; 78:2683-2688.
35. Zhou JW, Cheng XR, Cheng J.P., Zhou WX, Zhang YX. The activity and mRNA expression of beta-secretase, cathepsin D, and cathepsin B in the brain of senescence-accelerated mouse. J. Alzheimers Dis. 2012; 28:471-480.
36. Kumar VB, Franko M, Banks W.A., Kasinadhuni P., Farr SA, Vyas K, Choudhuri V, Morley JE. Increase in Presenilin 1 (PS1) levels in senescence-accelerated mice (SAMP8) may indirectly impair memory by affecting amyloid precursor protein (APP) processing. J. Exp. Biol. 2009; 212:494-498.
37. Fiorini A, Sultana R, Forster S., Perluigi M, Cenini G, Cini C., Cai J, Klein JB, Farr SA, Niehoff ML, Morley JE, Kumar VB, Butterfield DA. Antisense directed against PS-1 gene decreases brain oxidative markers in aged senescence accelerated mice (SAMP8) and reverses learning and memory impairment: A proteomics study. Free Radical Biol. Med. 2013; 65:1-14.
38. Varadarajan S, Yatin S, Aksenova M., Butterfield DA. Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. J. Struct. Biol. 2000; 130:184-208.
39. Kumar VB, Farr SA, Flood J.F., Kamlesh V., Franko M, Banks WA, Morley JE. Site-directed antisense oligonucleotide decreases the expression of amyloid precursor protein and reverses deficits in learning and memory in aged SAMP8 mice. Peptides. 2000; 21:1769-1775.
40. Poon HF, Joshi G, Sultana R., Farr SA, Banks WA, Morley JE, Calabrese V, Butterfield DA. Antisense directed at the Abeta region of APP decreases brain oxidative markers in aged senescence accelerated mice. Brain Res. 2004; 1018:86-96.
41. Movsesyan N, Ghochikyan A, Mkrtichyan M., Petrushina I, Davtyan H, Olkhanud P.B., Head E., Biragyn A, Cribbs DH, Agadjanyan MG. Reducing AD-like pathology in 3xTg-AD mouse model by DNA epitope vaccine - A novel immunotherapeutic strategy. PLoS One. 2008; 3:e2124.
42. Davtyan H, Mkrtichyan M, Movsesyan N., Petrushina I, Mamikonyan G, Cribbs D.H., Agadjanyan MG, Ghochikyan A. DNA prime-protein boost increased the titer, avidity and persistence of anti-Abeta antibodies in wild-type mice. Genet. Ther. 2010; 17:261-271.